Characterization of plasma acylcarnitines in patients under valproate monotherapy using ESI-MS/MS
- 1 November 2001
- journal article
- Published by Elsevier in Clinical Biochemistry
- Vol. 34 (8), 635-638
- https://doi.org/10.1016/s0009-9120(01)00272-7
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The Role of Carnitine Supplementation during Valproic Acid TherapyAnnals of Pharmacotherapy, 2000
- Plasma and hepatic carnitine and coenzyme A pools in a patient with fatal, valproate induced hepatotoxicity.Gut, 1995
- Impaired fatty acid oxidation in children on valproic acid and the effect of L‐carnitineNeurology, 1993
- Hepatotoxic effects in a child receiving valproate and carnitineThe Journal of Pediatrics, 1993
- Carnitine Disposition Before and During Valproate Therapy in Patients with EpilepsyEpilepsia, 1993
- Valproate, Carnitine Metabolism, and Biochemical Indicators of Liver FunctionEpilepsia, 1990
- L-Carnitine Replacement Therapy in Chronic Valproate TreatmentNeuropediatrics, 1990
- Serum Carnitine During Valproic Acid TherapyEpilepsia, 1986
- Carnitine deficiency and hyperammonemia associated with valproic acid therapyThe Journal of Pediatrics, 1982
- Decreased serum carnitine in valproate induced Reye syndromeEuropean Journal of Pediatrics, 1982